India’s Sun Pharma to acquire US-listed Organon in $11.8 billion deal

Investing.com Gold reports: India’s Sun Pharma to acquire US-listed Organon in $11.8 billion deal. Full body text was unavailable at ingest time, so this brief is based on headline context.